Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Additional evidence for antagonistic pleiotropic effects of APOE.

Zetterberg H, Alexander DM, Spandidos DA, Blennow K.

Alzheimers Dement. 2009 Jan;5(1):75. doi: 10.1016/j.jalz.2008.10.005. No abstract available.

PMID:
19118812
2.

Neuron-specific susceptibility to apolipoprotein E4.

Belinson H, Dolev I, Michaelson DM.

Neurobiol Aging. 2007 May;28(5):689-92; discussion 704-6. Epub 2006 Oct 4. Review. No abstract available.

PMID:
17023093
3.

Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis.

Han SD, Bondi MW.

Alzheimers Dement. 2008 Jul;4(4):251-4. doi: 10.1016/j.jalz.2008.02.006. Epub 2008 Apr 24.

PMID:
18631975
4.

ApoE genotype and family history in patients with dementia and cognitively intact spousal controls.

Zintl M, Schmitz G, Hajak G, Klünemann HH.

Am J Alzheimers Dis Other Demen. 2009 Aug-Sep;24(4):349-52. doi: 10.1177/1533317509333040. Epub 2009 Apr 16.

PMID:
19372276
5.

Early intervention in Alzheimer disease: The importance of APOE4 plus family history.

Corder EH, Caskey J.

Neurology. 2009 Dec 15;73(24):2054-5. doi: 10.1212/WNL.0b013e3181c67870. Epub 2009 Dec 9. No abstract available.

PMID:
20007523
6.

Genetics. Once shunned, test for Alzheimer's risk headed to market.

Couzin J.

Science. 2008 Feb 22;319(5866):1022-3. doi: 10.1126/science.319.5866.1022. No abstract available.

PMID:
18292309
7.

GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.

Ramirez-Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, Rosende-Roca M, Martinez-Lage P, Gutierrez M, Real LM, Lopez-Arrieta J, Gayan J, Antunez C, Gonzalez-Perez A, Tarraga L, Ruiz A.

J Nutr Health Aging. 2009 Mar;13(3):214-9.

PMID:
19262956
8.

Disclosure of the genetic risk of Alzheimer's disease.

Gordon SC, Landa D.

N Engl J Med. 2010 Jan 14;362(2):181-2; author reply 182. doi: 10.1056/NEJMc096300. No abstract available.

9.

Apolipoprotein E genotype and cerebral palsy.

Blackman JA.

Dev Med Child Neurol. 2010 Jul;52(7):600. doi: 10.1111/j.1469-8749.2009.03476.x. Epub 2009 Jan 5. No abstract available.

10.

Virology. Alzheimer's risk factor also aids HIV.

Youngsteadt E.

Science. 2008 Jun 20;320(5883):1577. doi: 10.1126/science.320.5883.1577a. No abstract available.

PMID:
18566258
11.

Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

Hulette CM, Welsh-Bohmer K.

Neurology. 2007 Feb 6;68(6):471; author reply 471. No abstract available. Erratum in: Neurology. 2007 Mar 27;68(13):1086.

PMID:
17283328
12.

Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.

Filippini N, Zarei M, Beckmann CF, Galluzzi S, Borsci G, Testa C, Bonetti M, Beltramello A, Ghidoni R, Benussi L, Binetti G, Frisoni GB.

J Magn Reson Imaging. 2009 May;29(5):1021-6. doi: 10.1002/jmri.21757.

PMID:
19388128
13.

Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.

Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ.

Ann Neurol. 2009 Jun;65(6):650-7. doi: 10.1002/ana.21696.

PMID:
19557866
14.

Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.

Feng L, Li J, Yap KB, Kua EH, Ng TP.

Am J Clin Nutr. 2009 Apr;89(4):1263-8. doi: 10.3945/ajcn.2008.26969. Epub 2009 Feb 25.

15.

Moderate alcohol consumption, apolipoprotein E, and neuroprotection.

Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemmiale G, Capurso A, Panza F.

Arch Neurol. 2009 Apr;66(4):541-2. doi: 10.1001/archneurol.2009.35. No abstract available.

PMID:
19364947
16.

[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].

Kálmán J.

Ideggyogy Sz. 2008 Jul 30;61(7-8):255-79. Review. Hungarian. No abstract available.

PMID:
18763482
17.

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A.

Neurology. 2009 Apr 28;72(17):1487-94. doi: 10.1212/WNL.0b013e3181a2e8d0. Epub 2009 Apr 1.

PMID:
19339712
18.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
19.

Predictive testing and Alzheimer disease.

Heger NE.

Clin Chem. 2014 Dec;60(12):1585-6. No abstract available.

20.

Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.

Seripa D, Panza F, Franceschi M, D'Onofrio G, Solfrizzi V, Dallapiccola B, Pilotto A.

Ageing Res Rev. 2009 Jul;8(3):214-36. Review.

PMID:
19496238
Items per page

Supplemental Content

Write to the Help Desk